ClinicalTrials.gov
public full text
Public Domain
Selenium Supplementation in Autoimmune Thyroiditis
Our aim is to investigate if selenium supplementation versus placebo adjuvant to the standard treatment with levothyroxine (LT4) in patients with autoimmune thyroiditis will lead to improved thyroid specific quality of life, and reduced autoimmune activity. The trial will include 472 participants (2 X 236) from four clinical trial sites.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Levothyroxine as Adjuvant to a Hypocaloric Diet for the Treatment of Obesity.#886570
- The Effect of Coffee on the Absorption of Thyroid Hormone in Patients With Thyroid Carcinoma#855166
- Nanoparticles in Thyroid Autoimmunity: Diagnostic and Therapeutic Applications#454622
- Novel Approaches to the Treatment of Hypothyroidism#1112607
- To Compare The Effects Of Two Doses Of Vandetanib In Patients With Advanced Medullary Thyroid Cancer#1172834
Record · ID 848089
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive